¶ … Merger
From the perspective of the firm, Pfizer and Wyeth can combine their diverse strengths and capabilities, and merge their talents and skills thus enabling them to become more profitable and lucrative. Doing so, they will be able to reach more clients, solidify their already existent client base, and, possibly, expand into other areas whilst establishing themselves in other states and/or in other parts of the globe.
More specifically, advantages to the firm include the fact that:
Quality staff, or additional skills, non-existent in one's own firm, can be acquired
That additional knowledge of the industry or sector can be gained;
That the business intelligence of other firm (or each particular company) can add to current experiences and knowledge;
That there is enhanced access to asses for new products and business development;
That the larger company can now gain a wider customer base, therefore increasing market share;
That there is diversification of services, products, and enhanced...
The mergence may offer the opportunity of reducing costs and overloads
8. The mergence reduces competition.
Mergers can leverage the value of the company whilst leading to tax gain and reducing costs. In this way, they can also help the company weather tough times. In numerous ways. Mergers benefit companies and as long as the mergence of Pfizer and Wyeth is accomplished in a smart way that is profitable to both, Pfizer and Wyeth, separately, stand a good chance of benefiting from their newly-formed partnership.
As regards the consumer, too, Pfizer being the world's foremost research company in matters of heath and wellness, and pooling up with Wyeth the rival drug maker can expand their resources and skills, a s well as knowledge to immeasurably advance the field of medicine and help it conquer a deal more diseases. Matching today's global environment, the mergence -- as Kindler, Pfizer's CEO pointed out, offer consumers "complementary patient centric units that match speed with the benefit of…
